HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavel Stourac Selected Research

Progressive Multifocal Leukoencephalopathy

5/2019The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavel Stourac Research Topics

Disease

5Multiple Sclerosis
08/2021 - 12/2008
2Relapsing-Remitting Multiple Sclerosis
03/2022 - 07/2021
1Fatigue
03/2022
1Lymphocytosis
07/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2020
1Inflammation (Inflammations)
10/2020
1Progressive Multifocal Leukoencephalopathy
05/2019

Drug/Important Bio-Agent (IBA)

2Glatiramer Acetate (Copaxone)FDA Link
08/2021 - 08/2012
2Natalizumab (Tysabri)FDA Link
07/2021 - 05/2019
1Biomarkers (Surrogate Marker)IBA
08/2021
1InterferonsIBA
08/2021
1CTLA-4 AntigenIBA
10/2020
1AntibodiesIBA
05/2019
1Interferon-betaIBA
08/2012
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2008
1tau Proteins (tau Protein)IBA
12/2008

Therapy/Procedure

2Therapeutics
03/2022 - 07/2021